A STUDY OF RITONAVIR-BOOSTED DANOPREVIR IN COMBINATION WITH PEGASYS (PEGINTERFERON ALFA-2A) AND COPEGUS (RIBAVIRIN) IN PATIENTS OF ASIAN ORIGIN WITH CHRONIC HEPATITIS C GENOTYPE 1 WITH OR WITHOUT CIRRHOSIS: